title: Undermining Value-Based Purchasing - Lessons from the Pharmaceutical Industry.
authors.affiliation: From Harvard Business School, Boston, and the National Bureau of Economic Research, Cambridge - both in Massachusetts (L.S.D.); the Kellogg School of Management, Northwestern University, Evanston, IL (C.J.O.); and the UCLA Anderson School of Management, Los Angeles (M.A.S.).
authors.forename: Leemore S
authors.initials: LS
authors.lastname: Dafny
authors.affiliation: From Harvard Business School, Boston, and the National Bureau of Economic Research, Cambridge - both in Massachusetts (L.S.D.); the Kellogg School of Management, Northwestern University, Evanston, IL (C.J.O.); and the UCLA Anderson School of Management, Los Angeles (M.A.S.).
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Ody
authors.affiliation: From Harvard Business School, Boston, and the National Bureau of Economic Research, Cambridge - both in Massachusetts (L.S.D.); the Kellogg School of Management, Northwestern University, Evanston, IL (C.J.O.); and the UCLA Anderson School of Management, Los Angeles (M.A.S.).
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Schmitt
mesh_terms: D017047:Cost Sharing; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006278:Medicare / Q000191:economics*; D011306:Prescription Fees; D014481:United States; D062505:Value-Based Purchasing